Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05057676 · ClinicalTrials.gov registry record · NA
Autoimmune Intervention Mastery Course Study
A NA study of Multiple Sclerosis and Fibromyalgia, sponsored by Terry L. Wahls.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT05057676: Recruiting NA study of Multiple Sclerosis and Fibromyalgia, sponsored by Terry L. Wahls.
NCT05057676 is a NA study of Multiple Sclerosis and Fibromyalgia that is actively recruiting participants, run by Terry L. Wahls. The registered enrollment target is 400 participants, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05057676, a NA study of Multiple Sclerosis and Fibromyalgia, is actively recruiting participants, sponsored by Terry L. Wahls.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remission with persisting fatigue.
Primary Outcome
Change in (MS 54 QoL MH) survey questions mean scores, range 0-100, higher number is better.
Conditions Studied
Interventions
- BEHAVIORAL Immediate Autoimmune Intervention Mastery Course (AIM)
- BEHAVIORAL Immediate Question and Answer sessions. (AIM Q and A sessions)
- BEHAVIORAL Delayed Autoimmune Intervention Mastery Course (delayed AIM course)
- BEHAVIORAL Delayed AIM Question and Answer sessions
Study Locations (1)
Iowa
- Univeristy of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
What NCT05057676 shows while recruiting
NCT05057676 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (32% lower).
The record links to 5 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 4 interventions - of which Immediate Autoimmune Intervention Mastery Course (AIM) is the first listed.
NCT05057676 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT05057676 about?
NCT05057676 is a clinical study titled "Autoimmune Intervention Mastery Course Study". The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remission with persisting fatigue.
What is the current status of trial NCT05057676?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2021-12-01. Estimated completion is 2027-12-01.
What conditions does trial NCT05057676 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Fibromyalgia, Post Acute Sequelae of COVID-19, Clinically Isolated Syndrome, Cancer in Remission With Persisting Fatigue.
What interventions are being tested in trial NCT05057676?
The interventions under investigation include: Immediate Autoimmune Intervention Mastery Course (AIM) (BEHAVIORAL), Immediate Question and Answer sessions. (AIM Q and A sessions) (BEHAVIORAL), Delayed Autoimmune Intervention Mastery Course (delayed AIM course) (BEHAVIORAL), Delayed AIM Question and Answer sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT05057676?
This trial is sponsored by Terry L. Wahls, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05057676 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05057676's enrollment target sits among peer trials
400 47th of 315 higher than 267 of 315 other Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Intermittent Hypoxia in Persons With Multiple Sclerosis
RECRUITING · NA
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Central Vein Sign in Multiple Sclerosis Extension Study
RECRUITING · NA
-
Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI